In vitro tests for drug hypersensitivity reactions: an ENDA / EAACI Drug Allergy Interest Group position paper
Year: 2016
Type: article
Abstract: Drug hypersensitivity reactions (DHRs) are a matter of great concern, both for outpatient and in hospital care. The evaluation of these patients is complex, because in vivo tests have a suboptimal sensitivity and can be time-consuming, expensive and potentially risky, especially drug provocation tests. There are several currently available in vitro methods that can be classified into two main groups: those that help to characterize the active phase of the reaction and those that help to identify the culprit drug. The utility of these in vitro methods depends on the mechanisms involved, meaning that they cannot be used for the evaluation of all types of DHRs. Moreover, their effectiveness has not been defined by a consensus agreement between experts in the field. Thus, the European Network on Drug Allergy and Drug Allergy Interest Group of the European Academy of Allergy and Clinical Immunology has organized a task force to provide data and recommendations regarding the available in vitro methods for DHR diagnosis. We have found that although there are many in vitro tests, few of them can be given a recommendation of grade B or above mainly because there is a lack of well-controlled studies, most information comes from small studies with few subjects and results are not always confirmed in later studies. Therefore, it is necessary to validate the currently available in vitro tests in a large series of well-characterized patients with DHR and to develop new tests for diagnosis.
Source: Allergy
DOI: 10.1111/all.12886
Authors: C. Mayorga, G. Celik, P. Rouzaire, P. Whitaker, P. Bonadonna, J. Rodrigues‐Cernadas, A. Vultaggio, K. Brockow, J. C. Caubet, J. Makowska, A. Nakonechna, A. Romano, M. I. Montañez, J. J. Laguna, G. Zanoni, J. L. Gueant, H. Oude Elberink, J. Fernandez, S. Viel, P. Demoly, M. J. Torres, In vitro tests for Drug Allergy Task Force of EAACI Drug Interest Group
Institutions: Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga, Universidad de Málaga, Ankara University, Université Clermont Auvergne, Centre Hospitalier Universitaire de Clermont-Ferrand, St James's University Hospital, Hospital de São João, Azienda Ospedaliero-Universitaria Careggi, Technical University of Munich, University Hospital of Geneva, Medical University of Lodz, Royal Liverpool and Broadgreen University Hospital NHS Trust, Broadgreen Hospital, Oasi Maria SS, I.R.C.C.S. Oasi Maria SS, Istituti di Ricovero e Cura a Carattere Scientifico, Andalusian Centre for Nanomedicine and Biotechnology, University of Verona, Inserm, Centre Hospitalier Régional et Universitaire de Nancy, Nutrition-Génétique et Exposition aux Risques Environnementaux, Université de Lorraine, University Medical Center Groningen, University of Groningen, Hospices Civils de Lyon, Hôpital Lyon Sud, Centre Hospitalier Universitaire de Montpellier, Hôpital Arnaud de Villeneuve, Université Pierre-et-Marie-Curie
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2301735730
